In Brief: Unigene Fortical
Executive Summary
Unigene Fortical: Unigene plans to file an NDA later this year for the injectable osteoporosis therapy based on a bioequivalence study compared to Miacalcin (Novartis/Sandoz). Unigene will seek marketing partners for the recombinant salmon calcitonin in the U.S. and Europe...